Compared with the control, knockdown of ITGA2 promoted apoptosis and cell cycle arrest, whereas overexpression of ITGA2 reduced apoptosis and cell cycle arrest, promoting cell growth and confirming that ITGA2 promotes lenvatinib drug resistance in liver cell carcinoma. Here, ITGA2 is linked to hepatocellular carcinoma.